Rifaximin for the Treatment of Irritable Bowel Syndrome

Clinical trial NCT00259155 · COMPLETED

Trial details

NCT number: NCT00259155
Sponsor: Cedars-Sinai Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Irritable Bowel Syndrome

Start date: 2003-07-01
Primary completion: 2007-01-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.